Department of Surgery, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Centre Amsterdam, De Boelelaan 1117, Amsterdam, 1081HV, the Netherlands.
Department of Gastroenterology, University Medical Center Utrecht, Utrecht, the Netherlands.
BMC Cancer. 2023 Dec 21;23(1):1266. doi: 10.1186/s12885-023-11734-0.
Shared decision-making has become of increased importance in choosing the most suitable treatment strategy for early rectal cancer, however, clinical decision-making is still primarily based on physicians' perspectives. Balancing quality of life and oncological outcomes is difficult, and guidance on patients' involvement in this subject in early rectal cancer is limited. Therefore, this study aimed to explore preferences and priorities of patients as well as physicians' perspectives in treatment for early rectal cancer.
In this qualitative study, semi-structured interviews were performed with early rectal cancer patients (n = 10) and healthcare providers (n = 10). Participants were asked which factors influenced their preferences and how important these factors were. Thematic analyses were performed. In addition, participants were asked to rank the discussed factors according to importance to gain additional insights.
Patients addressed the following relevant factors: the risk of an ostomy, risk of poor bowel function and treatment related complications. Healthcare providers emphasized oncological outcomes as tumour recurrence, risk of an ostomy and poor bowel function. Patients perceived absolute risks of adverse outcome to be lower than healthcare providers and were quite willing undergo organ preservation to achieve a better prospect of quality of life.
Patients' preferences in treatment of early rectal cancer vary between patients and frequently differ from assumptions of preferences by healthcare providers. To optimize future shared decision-making, healthcare providers should be aware of these differences and should invite patients to explore and address their priorities more explicitly during consultation. Factors deemed important by both physicians and patients should be expressed during consultation to decide on a tailored treatment strategy.
在选择早期直肠癌最适合的治疗策略时,共同决策变得越来越重要,然而,临床决策仍然主要基于医生的观点。平衡生活质量和肿瘤学结果是困难的,并且在早期直肠癌患者参与这一问题方面的指导是有限的。因此,本研究旨在探讨早期直肠癌患者和医生对治疗的偏好和优先事项。
在这项定性研究中,对 10 名早期直肠癌患者和 10 名医疗保健提供者进行了半结构化访谈。要求参与者回答哪些因素影响他们的偏好,以及这些因素的重要程度。进行了主题分析。此外,要求参与者根据重要性对讨论的因素进行排名,以获得更多的见解。
患者提到了以下相关因素:造口风险、肠道功能不良风险和治疗相关并发症。医疗保健提供者强调了肿瘤学结果,如肿瘤复发、造口风险和肠道功能不良。患者认为不良后果的绝对风险低于医疗保健提供者,并且非常愿意接受器官保存以获得更好的生活质量前景。
早期直肠癌患者的治疗偏好因人而异,且与医疗保健提供者的假设偏好经常存在差异。为了优化未来的共同决策,医疗保健提供者应该意识到这些差异,并在咨询中邀请患者更明确地探讨和解决他们的优先事项。在咨询中应该表达医生和患者都认为重要的因素,以决定量身定制的治疗策略。